Hyperscale Data cuts ATM to $100M but shows $49.8M raised at $0.41/share

What happened

Hyperscale Data announced an amendment to its at-the-market (ATM) sales agreement with Spartan Capital, reducing the maximum offering size from $300 million to $100 million. The company disclosed that under this ATM it has already sold 121,827,841 common shares for approximately $49.8 million in gross proceeds, implying an average price of about $0.41 per share. This follows earlier heavy ATM usage, as the company previously sold 137.6 million shares for $24.7 million under a separate $50 million ATM, reflecting a cumulative and substantial dilution of existing shareholders. The reduction in the ATM ceiling signals a smaller future overhang, but the remaining capacity of roughly $50 million could still translate into hundreds of millions of additional shares at current prices. No update was provided on the company's key operational milestone—the Phase 1 10MW AI colocation readiness targeted for September 21, 2026—leaving the investment case dependent on execution rather than financing optics.

Implication

Investors should interpret the ATM cut as a modest concession to shareholder concerns about dilution, but the disclosure that 121.8 million shares were sold at an average of $0.41 raises questions about the timing of those sales relative to the stock's recent trading range, which has been predominantly below $0.30, suggesting the company may have capitalized on earlier price strength. Even with the reduced ceiling, the company still has approximately $50 million of remaining ATM capacity, which at current prices could add more than 300 million shares, further eroding per-share value. The core thesis remains tied to the company's ability to deliver 10MW of AI colocation by the September 21, 2026 deadline, and without an update on that milestone, the risk of missing the target and reverting to a pure dilution story stays high. Given the lack of operational clarity and the ongoing reliance on equity financing, the WAIT rating remains appropriate, with the attractive entry near $0.14 and trim level above $0.32 still valid. Investors should monitor the next quarterly filing for evidence of Phase 1 commissioning and whether the company has begun to generate AI colocation revenue.

Thesis delta

The reduction in ATM size from $300 million to $100 million marginally lowers the dilution overhang, but the disclosure that 121.8 million shares have already been sold at an average price of $0.41 indicates that the company has aggressively used the facility, likely during periods of higher trading prices. This does not fundamentally change the reliance on equity issuance to fund the $100–$120 million retrofit, and the absence of any operational update on the Michigan AI colocation project means the investment thesis remains a WAIT. The key catalysts—Phase 1 readiness by September 21, 2026 and a slowdown in dilution—are still unconfirmed.